NM_152296.5:c.2267G>A
Variant summary
The NM_152296.5(ATP1A3):c.2267G>A (p.Arg756His) variant causes a missense change involving the alteration of a conserved nucleotide. The gene ATP1A3 is a known oncogene (CancerMine: 1 oncogene citations). The variant allele was found at a cumulative frequency of 0.000000687 (AC=1) in the gnomAD database across 1,455,136 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000000903. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.82). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000645400: This variant disrupts the p.Arg756 amino acid residue in ATP1A3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID:26400718, 27268479, 27634470, 27726050, 29066118, 29397530)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R756C: Pathogenic/Likely_pathogenic (ClinVar VariationId 425189, 2 stars) The variant has been observed in cBioPortal in 2 samples across 2 studies and 1 cancer type; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.).
Frequency
Consequence
NM_152296.5 missense
Scores
Clinical Significance
Conservation
Publications
- alternating hemiplegia of childhood 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
- ATP1A3-associated neurological disorderInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen, Illumina
- cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet
- developmental and epileptic encephalopathy 99Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- dystonia 12Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet
- encephalopathy, acute, infection-inducedInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- alternating hemiplegia of childhoodInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- complex neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 5 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000001, AC = 1 — absent/extremely rare (O3 moderate [+2]) | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 6 pathogenic, 0 benign (OR vs. background: 65.0); Variant does not impact splicing — splice-hotspot path not applicable | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 9.14 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_152296.5. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
ATP1A3 | MANE Select | c.2267G>A p.Arg756His | missense | Exon 17 of 23 | Prot: NP_689509.1 UniProt: | |
ATP1A3 | c.2306G>A p.Arg769His | missense | Exon 17 of 23 | Prot: NP_001243143.1 UniProt: | ||
ATP1A3 | c.2300G>A p.Arg767His | missense | Exon 17 of 23 | Prot: NP_001243142.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
ATP1A3 | MANE Select | c.2267G>A p.Arg756His | missense | Exon 17 of 23 | Prot: ENSP00000498113.1 UniProt: | |
ENSG00000285505 | n.2267G>A | non_coding_transcript_exon | Exon 17 of 25 | Prot: ENSP00000494711.1 UniProt: | ||
ATP1A3 | TSL:2 | c.2306G>A p.Arg769His | missense | Exon 17 of 23 | Prot: ENSP00000444688.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 4 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | AF: 6.87e-7 | AC:1 | Hom:0 | AN:1455136 | Cov:34 |
GnomAD4 genome | Cov:32 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00 | AC:0 | Hom:0 | AN:36930 | |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 30 | |
AlphaMissense | Pathogenic | 1.0 | |
BayesDel_addAF | Pathogenic | 0.58 | D |
BayesDel_noAF | Pathogenic | 0.59 | |
CADD | Pathogenic | 30 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Uncertain | 0.77 | D |
Eigen | Pathogenic | 0.91 | |
Eigen_PC | Pathogenic | 0.74 | |
FATHMM_MKL | Pathogenic | 0.99 | D |
FuncVEP CTI | Pathogenic | 1.0 | |
GPN-Star LLR | N/A | -7.4 | |
GPN-Star score | N/A | 7.4 | |
LIST_S2 | Uncertain | 0.95 | D |
M_CAP | Pathogenic | 0.87 | D |
MetaRNN | Pathogenic | 0.99 | D |
MetaSVM | Pathogenic | 1.1 | D |
Mutation Taster | N/A | 0/100 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 4.3 | H |
PhyloP100 | Pathogenic | 7.8 | |
popEVE | Uncertain | -5.0 | |
PrimateAI | Pathogenic | 0.89 | D |
PROVEAN | Uncertain | -3.7 | D |
REVEL | Pathogenic | 0.98 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.66 | |
VESM-3B | Benign | -12 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.010 | |
SpliceAI score (max) | Benign | 0.020 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.